About the author

Vikas Shukla

Vikas is a reporter and value investor. He has an MBA in finance and a deep interest in tech, science and politics.

  • John Smith

    1.4 billion insulin syringes are used each year in the u.s. alone. If one billion switch and the cost per use is say 3.50 then this makes sense. But this will be a global product and by 2025 and cases of diabetes will have increased substantially. The U.S. Only makes up 8% of diabetes world wide. Therefore I think the estimates may be low for the true potential.

Copyright © 2015 ValueWalk - Privacy Policy

Developed by ValueWalk Team